Figure 2

CRS and asthma clinical symptoms improved after the FESS. A, lung function after antigen challenge was assessed by recording FEV1 falling rate in the period of 0~8 h. B, overall clinical scores reported by patients. *, p < 0.05, compared with the 1^st scores within the same group.